Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) to Webcast First-Quarter 2007 Financial Results

CAMBRIDGE, Mass., April 19 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. will hold a live webcast of its conference call at 8:00 a.m. ET on Thursday, April 26, 2007. Dr. Deborah Dunsire, Chief Executive Officer, will host the call. Senior management will discuss the Company's first-quarter 2007 financial results and additional corporate activities. A presentation to accompany the conference call will also be available on the webcast. The Company will announce its financial results for this period in a press release to be issued on Thursday, April 26, 2007.prior to the conference call.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

The press release, presentation and the live webcast can be accessed by visiting the Investors section of the Company's website, http://www.millennium.com. Following the webcast, an archived version of the call will be available at the same address for 30 days.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.

Contact: Kyle Kuvalanka Investor Relations (617) 761-4734

Editors' Note: This press release is also available under the Media section of the Company's website at: www.millennium.com.

Photo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comMillennium Pharmaceuticals, Inc.

CONTACT: Kyle Kuvalanka, Investor Relations, Millennium Pharmaceuticals,Inc. +1-617-761-4734

Back to news